Literature DB >> 29084001

Assessing the borderline ventricle in a term infant: combining imaging and physiology to establish the right course.

Meryl S Cohen1.   

Abstract

PURPOSE OF REVIEW: The purpose of this review is to describe the challenges associated with the diagnosis and treatment of children with borderline ventricles. A borderline ventricle is one in which there is concern that it will not be able to support its circulation. If a biventricular repair is attempted and fails, outcome is often poor. Thus, this early decision is important. RECENT
FINDINGS: For the borderline right ventricle, options to add an additional source of pulmonary blood flow make the surgical strategy a bit more flexible than for patients with a borderline left ventricle. In general, outcome for a so-called one and one-half ventricle repair are generally good, though the long-term outcome and the effects of this physiology on lifelong exercise performance and quality of life remain to be seen. For the small left ventricle, often multiple surgeries are required to 'force' blood into the left ventricle and potentially help it grow. Though this strategy is successful in some, in others it results in significant residual cardiac issues including pulmonary hypertension.
SUMMARY: Determining whether a patient will be better off in the long term with a marginal biventricular repair versus a Fontan circulation remains one of the most difficult problems in the field of pediatric cardiology and cardiac surgery.

Entities:  

Mesh:

Year:  2018        PMID: 29084001     DOI: 10.1097/HCO.0000000000000466

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  2 in total

Review 1.  Small and borderline left ventricular outflow tract - a perplexing maladie.

Authors:  Manan Desai
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-01-15

2.  Prediction of biventricular repair by echocardiography in borderline ventricle.

Authors:  Xiao-Jing Ma; Guo-Ying Huang
Journal:  Chin Med J (Engl)       Date:  2019-09-05       Impact factor: 2.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.